Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Genmark Diagnostics (GNMK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 380,383
  • Shares Outstanding, K 57,029
  • Annual Sales, $ 70,760 K
  • Annual Income, $ -50,500 K
  • 60-Month Beta 1.55
  • Price/Sales 5.38
  • Price/Cash Flow N/A
  • Price/Book 15.57

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.21
  • Number of Estimates 4
  • High Estimate -0.20
  • Low Estimate -0.22
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +30.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.54 +1.95%
on 05/23/19
8.17 -18.36%
on 05/06/19
-0.43 (-6.06%)
since 04/24/19
3-Month
6.54 +1.95%
on 05/23/19
8.17 -18.36%
on 05/06/19
-0.64 (-8.76%)
since 02/22/19
52-Week
3.58 +86.31%
on 12/21/18
8.81 -24.29%
on 08/30/18
-0.33 (-4.71%)
since 05/24/18

Most Recent Stories

More News
GenMark Diagnostics to Participate in Upcoming Investor Conferences

GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in three upcoming investor...

GNMK : 6.67 (unch)
Genmark Diagnost Has Returned 51.0% Since SmarTrend Recommendation (GNMK)

SmarTrend identified an Uptrend for Genmark Diagnost (NASDAQ:GNMK) on January 3rd, 2019 at $4.82. In approximately 4 months, Genmark Diagnost has returned 50.99% as of today's recent price of $7.27.

GNMK : 6.67 (unch)
Genmark Diagnost Shares Up 61.2% Since SmarTrend's Buy Recommendation (GNMK)

SmarTrend identified an Uptrend for Genmark Diagnost (NASDAQ:GNMK) on January 3rd, 2019 at $4.82. In approximately 4 months, Genmark Diagnost has returned 61.16% as of today's recent price of $7.76.

GNMK : 6.67 (unch)
GenMark Diagnostics to Present at the Bank of America Merrill Lynch Health Care Conference

GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the Bank of America Merrill...

GNMK : 6.67 (unch)
GenMark Diagnostics Reports First Quarter 2019 Results

GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the quarter ended March 31, 2019.

GNMK : 6.67 (unch)
GenMark Diagnostics Expands Commercial Team

GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that it has expanded its commercial team in North America with...

GNMK : 6.67 (unch)
GenMark Diagnostics Schedules First Quarter 2019 Financial Results Conference Call for April 30, 2019

GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its first quarter earnings results after market close on Tuesday, April 30, 2019. Management will hold a conference call...

GNMK : 6.67 (unch)
GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Gram-Negative Panel

GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that it has received FDA 510(k) market clearance from the U.S....

GNMK : 6.67 (unch)
Market Trends Toward New Normal in ZTO Express (Cayman), ProPetro Holding, Social Reality, The Habit Restaurants, GenMark Diagnostics, and Power Integrations -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ZTO Express (Cayman) Inc. (NYSE:ZTO),...

SRAX : 4.76 (+2.37%)
SCRI : 1.3000 (unch)
ZTO : 17.95 (-0.55%)
GNMK : 6.67 (unch)
POWI : 67.46 (-0.15%)
HABT : 10.94 (-1.17%)
PUMP : 18.81 (-2.44%)
Genmark Diagnost Has Returned 48.3% Since SmarTrend Recommendation (GNMK)

SmarTrend identified an Uptrend for Genmark Diagnost (NASDAQ:GNMK) on January 3rd, 2019 at $4.82. In approximately 3 months, Genmark Diagnost has returned 48.29% as of today's recent price of $7.14.

GNMK : 6.67 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade GNMK with:

Business Summary

GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor' XT-8 system is the second generation in GenMark Dx's eSensor' platform, utilizing electrochemical detection technology to detect nucleic...

See More

Key Turning Points

2nd Resistance Point 6.92
1st Resistance Point 6.79
Last Price 6.67
1st Support Level 6.58
2nd Support Level 6.50

See More

52-Week High 8.81
Fibonacci 61.8% 6.81
Last Price 6.67
Fibonacci 50% 6.20
Fibonacci 38.2% 5.58
52-Week Low 3.58

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar